Literature DB >> 23391957

Disseminated cysticercosis with a right common femoral vein thrombosis.

Utpal Kant Singh1, Rajniti Prasad, Prashant Bhushan, Om P Mishra.   

Abstract

Disseminated cysticercosis is an uncommon presentation of cysticercosis. Less than 10 cases of disseminated cysticercosis have been reported worldwide in children. We report the case of an 8-year-old boy with disseminated cysticercosis, who had presented with a swelling of the body for 1 month and proptosis of the eyeballs for 14 days. On examination, he had bilateral proptosis, subcutaneous nodules and hypertrophy of muscles of the limbs, neck and face. The CT cranium was normal, but the orbit showed bilateral bulky extraocular muscles heterogeneous in their whole length. The MRI cranium and whole body showed multiple non-enhancing vesicular cysts involving the brain, extraocular muscle, heart, trunk and muscles of the extremities and subcutaneous tissues. A Doppler study of the femoral vein showed thrombosis of the right common femoral vein. He was managed with corticosteroid, albendazole, phenytoin sodium, low-molecular-weight heparin followed by warfarin for 6 months and recovered completely.

Entities:  

Mesh:

Year:  2013        PMID: 23391957      PMCID: PMC3604459          DOI: 10.1136/bcr-2012-008175

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  [Ocular cysticercosis, typical forms and treatment].

Authors:  M Berche; B Hayot; M Mokrane; G Najjar; E Bouzas
Journal:  Ophtalmologie       Date:  1990 Jul-Aug

2.  Orbital cysticercosis: diagnosis and treatment controversies.

Authors:  Ana Rita Sandes; Ana Mouzinho; Paula Valente
Journal:  Pediatr Infect Dis J       Date:  2007-02       Impact factor: 2.129

3.  Proptosis of eyeball in children with medial rectus cysticercosis: report of 2 cases.

Authors:  Rajniti Prasad; Narendra Bagri; Om Prakash Mishra; Mahendra Kumar Singh
Journal:  Eur J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 2.597

4.  Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy.

Authors:  P Singhi; M Ray; S Singhi; N Khandelwal
Journal:  J Child Neurol       Date:  2000-04       Impact factor: 1.987

Review 5.  Neurocysticercosis: updated concepts about an old disease.

Authors:  Hector H Garcia; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2005-10       Impact factor: 44.182

Review 6.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

7.  [Pseudohypertrophic myopathy caused by cysticercosis. Report of a case].

Authors:  M I Lana-Peixoto; M A Lana-Peixoto; G Belisário Campos
Journal:  Arq Neuropsiquiatr       Date:  1985-12       Impact factor: 1.420

Review 8.  Current consensus guidelines for treatment of neurocysticercosis.

Authors:  Hector H García; Carlton A W Evans; Theodore E Nash; Osvaldo M Takayanagui; A Clinton White; David Botero; Vedantam Rajshekhar; Victor C W Tsang; Peter M Schantz; James C Allan; Ana Flisser; Dolores Correa; Elsa Sarti; Jon S Friedland; S Manuel Martinez; Armando E Gonzalez; Robert H Gilman; Oscar H Del Brutto
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

9.  Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel.

Authors:  N Wadia; S Desai; M Bhatt
Journal:  Brain       Date:  1988-06       Impact factor: 13.501

10.  Disseminated cysticercosis: a case report and review of the literature.

Authors:  Ashish Bhalla; Ashwani Sood; Atul Sachdev; Vandna Varma
Journal:  J Med Case Rep       Date:  2008-04-30
View more
  1 in total

1.  Disseminated cysticercosis and Kaposi sarcoma in a child with HIV/AIDS: A case report.

Authors:  David W McCormick; Jason M Bacha; Nader K El-Mallawany; Carrie L Kovarik; J S Slone; Liane R Campbell
Journal:  BMC Infect Dis       Date:  2020-04-25       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.